Amira Khater/LinkedIn
Dec 15, 2025, 11:00
Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy
Amira Khater, Clinical Pharmacy Specialist at Sentara Healthcare, shared on LinkedIn:
”Important trial reinforcing that in patients with ischemic stroke/TIA plus AF and atherosclerotic disease, anticoagulant monotherapy is sufficient.
Adding antiplatelet therapy increased bleeding without improving ischemic outcomes—a key stewardship message.”
Read the full article here.
Article: Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis. A Randomized Clinical Trial
Authors: Shuhei Okazaki, Kanta Tanaka, Yukako Yazawa et al.
Stay updated on all scientific advances with Hemostasis Today.
-
May 10, 2026, 16:20Joshua Ngimbwa: How Sex and Socioeconomic Factors Influence Stroke Outcomes in Tanzania
-
May 10, 2026, 16:18Gustavo Monnerat: How Thousands of Fake References Slipped Into Biomedical Literature
-
May 10, 2026, 16:13Dalius Jatužis: Our AI-Driven Automated Stroke Registry Data Extraction Gets Best Poster Award at ESOC 2026
-
May 10, 2026, 16:11Full House for Breakfast with the Experts – American Society for Apheresis
-
May 10, 2026, 15:59Luma Mahairi: AI and Digital Hematology Are Transforming Emergency Laboratory Care in 2026
-
May 10, 2026, 15:55Reza Shojaei: Designing Blood Systems for Chronic Demand
-
May 10, 2026, 15:52Alan Nurden: How Platelets Construct a Thrombus Under Flow
-
May 10, 2026, 15:36Manoj Khadka: Omega-3s and Cardiovascular Outcomes in Hemodialysis
-
May 10, 2026, 15:33Abdul Mannan: Here’s when Your POC INR Machine Misleads You